Showing results (2341-2350 of 3,086) with videos related to
Sort By:
Pageof 309
Drug Safety|November 8, 2017
Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative StudyHsien-Yi Chiu, Wei-Lun Chang, Tsen-Fang Tsai, et al.Drug Safety|July 19, 2015
Photosensitivity with Angiotensin II Receptor Blockers: A Retrospective Study Using Data from VigiBase(®)Ermelinda Viola, Anna Coggiola Pittoni, Agnes Drahos, et al.Drug Safety|February 11, 2025
Risk of Fracture Associated with Pregabalin or Mirogabalin Use: A Case-Case-Time-Control Study Based on Japanese Health Insurance Claims DataHinako Wakabayashi, Toshiki Fukasawa, Satomi Yoshida, et al.Drug Safety|February 11, 2025
Emerging Tools to Support DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver DiseasesJasmine Amirzadegan, Bereket Tesfaldet, Y Veronica Pei, et al.Drug Safety|February 8, 2025
Drug Induced Liver Injury: Highlights and Controversies in the 2023 LiteratureHarjit Singh, Bryce F Kunkle, Angela R Troia, et al.Drug Safety|January 28, 2025
Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in AfricaRobin Schaefer, L Donaldson, A Chigome, et al.Drug Safety|January 9, 2025
Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping ReviewSu Golder, Dongfang Xu, Karen O'Connor, et al.Drug Safety|December 2, 2024
Adverse Drug Events in Ambulatory Care: A Cross-Sectional StudyJoseph M Plasek, Mary G Amato, Abigail Salem, et al.Drug Safety|December 17, 2024
Use of Reporting Recommendation Intended for Pharmaceutical Risk Minimisation Evaluation Studies (RIMES) Checklist in Risk Minimisation/Mitigation Studies: A Review and SurveySamantha E Duckworth, Sophie Druelles, Emily Brouwer, et al.Pageof 309